Josh Arnold Investment Consultant LLC Acquires New Position in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Josh Arnold Investment Consultant LLC has made a new investment of approximately $1.33 million in Acadia Healthcare Company, acquiring 44,000 shares, which now represents 1.1% of their portfolio.
• Acadia Healthcare recently reported $0.83 earnings per share for the last quarter, exceeding expectations and reflecting a 9.2% revenue increase compared to the previous year.
• Several analysts have revised their price targets for Acadia Healthcare, with the average target now set at $40.77, indicating a "Moderate Buy" consensus among analysts.

Josh Arnold Investment Consultant LLC purchased a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 44,000 shares of the company's stock, valued at approximately $1,334,000. Acadia Healthcare comprises approximately 1.1% of Josh Arnold Investment Consultant LLC's investment portfolio, making the stock its 10th largest holding.

Other hedge funds and other institutional investors have also bought and sold shares of the company. PNC Financial Services Group Inc. grew its position in shares of Acadia Healthcare by 10.3% during the first quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company's stock valued at $202,000 after purchasing an additional 622 shares in the last quarter. LPL Financial LLC boosted its position in shares of Acadia Healthcare by 1.2% during the first quarter. LPL Financial LLC now owns 56,527 shares of the company's stock valued at $1,651,000 after buying an additional 697 shares during the period. Quantinno Capital Management LP boosted its position in shares of Acadia Healthcare by 9.0% during the fourth quarter. Quantinno Capital Management LP now owns 8,695 shares of the company's stock valued at $345,000 after buying an additional 721 shares during the period. UMB Bank n.a. boosted its holdings in shares of Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after purchasing an additional 755 shares during the period. Finally, Covestor Ltd boosted its holdings in shares of Acadia Healthcare by 56.0% in the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock valued at $69,000 after purchasing an additional 812 shares during the period.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC traded up $0.76 on Tuesday, hitting $23.30. The company's stock had a trading volume of 2,624,590 shares, compared to its average volume of 2,221,939. The stock has a 50 day moving average of $22.21 and a 200-day moving average of $24.59. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market capitalization of $2.15 billion, a price-to-earnings ratio of 15.43, a price-to-earnings-growth ratio of 4.67 and a beta of 0.89. Acadia Healthcare Company, Inc. has a 12-month low of $17.13 and a 12-month high of $79.82.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.71 by $0.12. The firm had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. Acadia Healthcare's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently commented on ACHC. Stephens raised shares of Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Guggenheim cut their target price on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Mizuho lowered their price target on shares of Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating on the stock in a report on Wednesday, August 13th. Royal Bank Of Canada lowered their target price on shares of Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 13th. Finally, KeyCorp lowered their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Nine equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, Acadia Healthcare presently has an average rating of "Moderate Buy" and an average target price of $40.77.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.